BioCentury | Mar 11, 2013
Product Development

Neomics' new tricks

...KRS ), often highly expressed in squamous cell lung carcinoma (SCLC) and expressed in adenocarcinoma; glycyl-tRNA synthetase (GARS)...
...diagnostic; Ildong Pharmaceutical Co. Ltd. and Yooyoung Pharmaceutical Co. Ltd. are developing biologics using the GARS...
Items per page:
1 - 1 of 1